ReviewInfectious disease clinics of North America2013
Impact of multidrug-resistant organisms on patients considered for lung transplantation.
Review in Infectious disease clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 36 citations in OpenAlex.
- Leveraging machine learning to predict de novo skin malignancy following lung transplantation.Lung cancer management · 2026Article
- Prevention and Management of Infections in Lung Transplant Recipients.Journal of clinical medicine · 2023Review
- Prognostic impact of preoperative respiratory colonization on early-onset pneumonia after lung transplantation.Journal of thoracic disease · 2022Article
- Bacterial infections in lung transplantation.Journal of thoracic disease · 2021Review
- Developments in lung transplantation over the past decade.European respiratory review : an official journal of the European Respiratory Society · 2020Review
- Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients.Annals of translational medicine · 2020Review
- Lung Abscess: An Early Complication of Lung Transplantation in a Patient with Cystic Fibrosis.International journal of organ transplantation medicine · 2017Article
- AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.Journal of bacteriology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Infections with multidrug-resistant organisms are a growing problem in lung transplant recipients. Carriage of drug-resistant bacteria and fungi before transplantation is an important risk factor for such infections. In that regard Pseudomonas aeruginosa and species of Burkholderia, Acinetobacter, non-tuberculous mycobacteria and Scedosporium are particularly important. An understanding of the impact of these organisms is essential to the evaluation of lung transplant candidates. The microbiology, epidemiology, clinical manifestations, and approach to these pathogens before transplant are reviewed in this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.